AZD8330 First Time in Man in Patients With Advanced Malignancies
NCT00454090
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
83
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Interventions
DRUG:
AZD8330
Sponsor
AstraZeneca